148 related articles for article (PubMed ID: 1936106)
1. Familial defective apo B-100, characterization of an Italian family.
Corsini A; McCarthy BJ; Granata A; Soria LF; Fantappiè S; Bernini ; Romano C; Romano L; Fumagalli R; Catapano AL
Eur J Clin Invest; 1991 Aug; 21(4):389-97. PubMed ID: 1936106
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a family with moderate hypercholesterolemia and binding defective low density lipoprotein.
Catapano AL; Corsini A; Mazzotti M; Granata A; Uboldi P; Maggi FM; Romano L; Romano C; Fantappiè S; Fumagalli R
Eur J Epidemiol; 1992 May; 8 Suppl 1():26-32. PubMed ID: 1505652
[TBL] [Abstract][Full Text] [Related]
3. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
[TBL] [Abstract][Full Text] [Related]
5. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
6. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
Wenham PR; Henderson BG; Penney MD; Ashby JP; Rae PW; Walker SW
Atherosclerosis; 1997 Mar; 129(2):185-92. PubMed ID: 9105560
[TBL] [Abstract][Full Text] [Related]
7. The affinity of low-density lipoproteins and of very-low-density lipoprotein remnants for the low-density lipoprotein receptor in homozygous familial defective apolipoprotein B-100.
Gallagher JJ; Myant NB
Atherosclerosis; 1995 Jun; 115(2):263-72. PubMed ID: 7661885
[TBL] [Abstract][Full Text] [Related]
8. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
Myant NB
Atherosclerosis; 1993 Dec; 104(1-2):1-18. PubMed ID: 8141833
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
[TBL] [Abstract][Full Text] [Related]
10. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
[TBL] [Abstract][Full Text] [Related]
11. Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.
Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
Klin Wochenschr; 1991 May; 69(7):320-4. PubMed ID: 2067318
[TBL] [Abstract][Full Text] [Related]
12. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
Weisgraber KH; Innerarity TL; Newhouse YM; Young SG; Arnold KS; Krauss RM; Vega GL; Grundy SM; Mahley RW
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9758-62. PubMed ID: 3200853
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of species of low-density lipoprotein with defective clearance in patients with primary moderate hypercholesterolaemia.
Vega GL; Grundy SM
J Intern Med; 1992 Nov; 232(5):405-13. PubMed ID: 1453124
[TBL] [Abstract][Full Text] [Related]
14. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.
Innerarity TL; Weisgraber KH; Arnold KS; Mahley RW; Krauss RM; Vega GL; Grundy SM
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6919-23. PubMed ID: 3477815
[TBL] [Abstract][Full Text] [Related]
15. Familial defective apolipoprotein B100: clinical characteristics of 54 cases.
Rauh G; Keller C; Kormann B; Spengel F; Schuster H; Wolfram G; Zöllner N
Atherosclerosis; 1992 Feb; 92(2-3):233-41. PubMed ID: 1632851
[TBL] [Abstract][Full Text] [Related]
16. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
[TBL] [Abstract][Full Text] [Related]
17. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
[TBL] [Abstract][Full Text] [Related]
18. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
[TBL] [Abstract][Full Text] [Related]
19. Identification of the apo B-3500 mutation in the Norwegian population.
Leren TP; Rødningen OK; Tonstad S; Røsby O; Urdal P; Ose L
Scand J Clin Lab Invest; 1995 May; 55(3):217-21. PubMed ID: 7638555
[TBL] [Abstract][Full Text] [Related]
20. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
